Apricus mulls options; to sell U.S. rights to Vitaros

(Reuters) - Apricus Biosciences Inc said on Monday it was considering options for the company and looking to sell the U.S. rights to its erectile dysfunction cream Vitaros, after the Food and Drug Administration asked it to make a new formula for the product.

Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

See also

Ferrari Powers Through a Curve

The high-end car maker navigates a tricky transition with its high valuation intact, but faces challenges.

0 0

Just How 'Open' Are Open Office Plans?

Open offices are designed to encourage more effective collaboration. But many people who work in them choose to isolate themselves instead.

0 0

Whoops, looks like something went wrong.